Equity Residential (EQR)
NYSEReal EstateReit - ResidentialSnapshot 2026-07-07
$70.15+0.31%
Close 2026-07-07 · 1-day change
Reading EQR? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track EQR free→NYSEReal EstateReit - ResidentialSnapshot 2026-07-07
Reading EQR? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track EQR free→Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Real Estate is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Management is running behind on a stated commitment.
View ThesisRevenue is contracting — down about 8% over the past year.
View GrowthManagement screens weak on guidance credibility.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationRelatively steady — typically moves about 1% a day.
View RiskEquity Residential's growth depends on the potential merger with AvalonBay. This merger could significantly boost revenue growth. Revenue grew 2.2% year over year, and the last quarter beat expectations. The stock trades at 13× P/FFO, below the peer median of 16×. The price reflects less growth than forecasted, indicating modest expectations. If EQR cuts guidance on the next call, the stock could drop. Peer multiples imply a price about 18% below where it trades.
Trailing returns as of 2026-07-07. EQR is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 21 analysts currently covering EQR (as of Jul 2026).
Based on 9 Wall Street analysts offering 12-month price targets for EQR in the last 4 months.
A consensus fair price across 13 valuation methods, at three horizons. Current price $70.15. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Multi-Family Residential REITs — fair value, gap to price, and forward P/E.
Merger enhances growth potential and market position.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-07. EPS is implied from price ÷ P/E. Not investment advice.
Current $70.15
The last 12 months of price, then the range of analyst 12-month targets from today’s $70.15.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Potential merger could significantly boost revenue growth.
Concerns over merger viability could impact growth.
High coastal exposure presents risks to revenue growth.
High coastal exposure presents risks to revenue growth.